BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...been reported in peer reviewed publications by AUB and NIH. At least one other company, Genprex Inc....
BioCentury | Aug 10, 2018
Company News

Genprex to evaluate effect of Oncoprex on checkpoint inhibition with MD Anderson

...University of Texas MD Anderson Cancer Center (Houston, Texas) aimed at evaluating the effect of Genprex's...
...anti-CTLA-4 therapies. MD Anderson will provide all necessary personnel, equipment, supplies, facilities and resources for Genprex...
...to treat non-small cell lung cancer (NSCLC). Genprex will pay $2 million to MD Anderson. Genprex Inc....
BioCentury | Jul 13, 2018
Finance

Pause for politics

...4/18/18 $108.0 $414.0 $446.8 8% Medigen Vaccine Biologics Corp. (TPEx:6547) 4/17/18 $17.7 $147.9 $176.6 19% Genprex Inc....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...ProLung Inc. 8/7/17 $7M Devt (diagnostic) Sofiva Genomics Co. Ltd. (TPEx-E:6615) 7/31/17 TBD Mkt (diagnostic) Genprex Inc....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...D) 8/15/17 TBD Mkt (drug) Sofiva Genomics Co. Ltd. (TPEx-E:6615) (D) 7/31/17 TBD Mkt (diagnostic) Genprex Inc....
BioCentury | Jul 28, 2017
Financial News

Genprex proposes $24.5M IPO

...On July 20, cancer company Genprex Inc. (Austin, Texas) proposed to raise up to $24.5 million in...
...in a best efforts IPO underwritten by Network 1 Financial Securities. Genprex Inc. , Austin, Texas Julian Zhu Genprex Inc....
BioCentury | Jan 27, 2017
Clinical News

Oncoprex: Interim Ph II data

...patients and is being conducted at the University of Texas MD Anderson Cancer Center . Genprex Inc....
...dose (MTD); overall response rate (ORR) Status: Interim Phase II data Milestone: NA Jaime De Leon FUS1 nanoparticles Oncoprex Genprex Inc. Tumor...
BioCentury | Apr 23, 2012
Clinical News

Genprex preclinical data

...for all). Data were presented at the American Association for Cancer Research meeting in Chicago. Genprex...
...Genentech Inc. , a unit of Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland), and by Roche elsewhere. Genprex Inc....
Items per page:
1 - 8 of 8
BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...been reported in peer reviewed publications by AUB and NIH. At least one other company, Genprex Inc....
BioCentury | Aug 10, 2018
Company News

Genprex to evaluate effect of Oncoprex on checkpoint inhibition with MD Anderson

...University of Texas MD Anderson Cancer Center (Houston, Texas) aimed at evaluating the effect of Genprex's...
...anti-CTLA-4 therapies. MD Anderson will provide all necessary personnel, equipment, supplies, facilities and resources for Genprex...
...to treat non-small cell lung cancer (NSCLC). Genprex will pay $2 million to MD Anderson. Genprex Inc....
BioCentury | Jul 13, 2018
Finance

Pause for politics

...4/18/18 $108.0 $414.0 $446.8 8% Medigen Vaccine Biologics Corp. (TPEx:6547) 4/17/18 $17.7 $147.9 $176.6 19% Genprex Inc....
BioCentury | Jan 13, 2018
Finance

Choosy investors

...ProLung Inc. 8/7/17 $7M Devt (diagnostic) Sofiva Genomics Co. Ltd. (TPEx-E:6615) 7/31/17 TBD Mkt (diagnostic) Genprex Inc....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...D) 8/15/17 TBD Mkt (drug) Sofiva Genomics Co. Ltd. (TPEx-E:6615) (D) 7/31/17 TBD Mkt (diagnostic) Genprex Inc....
BioCentury | Jul 28, 2017
Financial News

Genprex proposes $24.5M IPO

...On July 20, cancer company Genprex Inc. (Austin, Texas) proposed to raise up to $24.5 million in...
...in a best efforts IPO underwritten by Network 1 Financial Securities. Genprex Inc. , Austin, Texas Julian Zhu Genprex Inc....
BioCentury | Jan 27, 2017
Clinical News

Oncoprex: Interim Ph II data

...patients and is being conducted at the University of Texas MD Anderson Cancer Center . Genprex Inc....
...dose (MTD); overall response rate (ORR) Status: Interim Phase II data Milestone: NA Jaime De Leon FUS1 nanoparticles Oncoprex Genprex Inc. Tumor...
BioCentury | Apr 23, 2012
Clinical News

Genprex preclinical data

...for all). Data were presented at the American Association for Cancer Research meeting in Chicago. Genprex...
...Genentech Inc. , a unit of Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland), and by Roche elsewhere. Genprex Inc....
Items per page:
1 - 8 of 8